TB-500
Peptidă de cercetare asociată cu repararea țesuturilor și recuperare
Product Specifications
Description
All presented information is based on scientific publications which can be found at the end of product description below.
Thymosin Beta-4 (TB-500) este prezentată ca o peptidă de cercetare asociată cu repararea țesuturilor, regenerarea, vindecarea rănilor și aplicații legate de recuperare. Produsul este destinat exclusiv cercetării științifice și nu este pentru uz diagnostic, terapeutic sau de consum uman.
Research Use Only: The product is intended for scientific research and development purposes only. Chemical substances shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals. Intended only for in-vitro research, such as Receptor-ligand binding studies, Enzyme activity assays, Cell proliferation assays, Cell signaling assays, Epitope mapping, etc.
🇪🇺 EU & UK Shipped • Free over €300 • 2-5 Business Days
Frequently asked questions
- TB-500 is a synthetic 17-amino-acid fragment derived from the central actin-binding region of Thymosin Beta-4 (Tβ4), a 43-amino-acid protein found in most mammalian cells. The fragment retains the conserved LKKTET actin-binding motif. Molecular weight is approximately 2.0-2.2 kDa depending on terminal modifications.
- Each batch is HPLC-verified at ≥99% purity, with mass spectrometry confirming the molecular identity. A Certificate of Analysis is included with every shipment.
- Lyophilised TB-500 is stable at -20 °C in a sealed, desiccant-protected vial for long-term storage. Reconstituted solutions are less stable — single-use aliquots are recommended to avoid freeze-thaw cycles, which can degrade the peptide.
- TB-500 (and full-length Tβ4) has been studied in preclinical models of skin wound healing, corneal repair, myocardial infarction, skeletal muscle injury, and central nervous system damage. The mechanism of interest is G-actin sequestration and downstream effects on cell migration.
- No. TB-500 is not approved by FDA, EMA, or any other regulator for human or veterinary use. WADA classifies it under the S0 Non-Approved Substances category. It is supplied for laboratory research only.
